Evidence map›Paper›PMID 39553742›Full record

ArticleTransplantation direct2024

Protocol and Statistical Analysis Plan for a Comparative Interrupted Time Series Evaluation of the Impact of Deemed Consent for Organ Donation Legislative Reform in Nova Scotia, Canada.

Matthew J Weiss, Kristina Krmpotic, Stephen Beed, Sonny Dhanani, Jade Dirk, David Hartell, Cynthia Isenor, Nick Lahaie, Scott T Leatherdale, Kara Matheson and 5 more

Abstract read
In one paragraph

Article in Transplantation direct, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Matthew J WeissTransplant Québec, Montréal, QC, Canada.
Kristina KrmpoticLegacy of Life Provincial Organ Donation, Nova Scotia Health, Halifax, NS, Canada.
Stephen BeedLegacy of Life Provincial Organ Donation, Nova Scotia Health, Halifax, NS, Canada.
Sonny DhananiCanadian Donation and Transplant Research Program, Edmonton, AB, Canada.
Jade DirkDepartment of Research and Innovation, Nova Scotia Health, Halifax, NS, Canada.
David HartellHartell Consulting, Ottawa, ON, Canada.
Cynthia IsenorNova Scotia Health, Critical Care, Provincial Organ Donation Program, Respiratory Therapy, Burns and Plastics, Central Zone, Halifax, NS, Canada.
Nick LahaieDeceased Donation, Canadian Blood Services, Ottawa, ON, Canada.
Scott T LeatherdaleSchool of Public Health Sciences, University of Waterloo, Waterloo, ON, Canada.
Kara MathesonResearch Methods Unit, Research, Innovation and Discovery, Nova Scotia Health, Halifax, NS, Canada.
Karthik TennankoreDepartment of Medicine, Division of Nephrology, Nova Scotia Health, Halifax, NS, Canada.
Gail Tomblin-MurphyNova Scotia Health, Research, Innovation and Discovery, Halifax, NS, Canada.
Amanda VinsonDepartment of Medicine, Division of Nephrology, Nova Scotia Health, Halifax, NS, Canada.
Hans VorsterPatient Partner, Canadian Donation and Transplant Research Program, Edmonton, AB, Canada.
Caroline KingDepartment of Research and Innovation, Nova Scotia Health, Halifax, NS, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Canadian province of Nova Scotia recently became the first North American jurisdiction to implement deemed consent for deceased organ donation as part of a comprehensive legislative reform of their donation and transplantation system. This study will examine the performance metrics and effectiveness of this policy in comparison with other Canadian provinces via a natural experiment evaluation. We will use a cross-sectional controlled interrupted time series quasi-experimental design. Our primary outcome will be consent for deceased donation as confirmed at the time of eligibility (prior registered intent to donate will be noted but not be considered positive unless affirmed at the time of eligibility). Secondary outcomes will include identification and referral of patients who are potential donors, rates of family override of previously registered intent to donate, and donation and transplantation rates per million population. Data will be collected from potential donor audits in Nova Scotia and 3 control provinces (provinces in Canada without deemed consent policies). Study outcomes will be compared in Nova Scotia relative to control provinces in the 3 y before and 3 y after the implementation of legislative reform. These provinces were selected as having systems resembling those of Nova Scotia but without deemed consent.Using controlled interrupted time series methodology compared with other Canadian provinces with otherwise similar systems, we aim to isolate the impact of the deemed consent aspect of legislative reform in Nova Scotia using a robust natural experiment evaluation design as much as possible. Careful selection of outcome measures will allow donation and transplantation stakeholders to properly evaluate if similar reforms should be considered in their jurisdictions.

Identifiers

PMID39553742
PMCPMC11567700

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.